Response Biomedical Receives U.S. FDA 510(k) Market Clearance of Rapid Influenza A+B Test
17 April 2008
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) announced today that it received a U.S. Food and Drug Administration (FDA) 510(k) clearance to market...
More...
  Response Biomedical Corporation Reports 2007 Financial Results
31 March 2008
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) reported that it recorded total revenues of $4,084,116 and a net loss of $13,901,041 or ($0.12) per share...
More...
  Response Biomedical Corporation Moves to New Facility
20 March 2008
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that it plans to move to its new state-of-the-art global headquarters....
More...
  Response Biomedical Corporation Receives Approval for TSX Listing
20 December 2007
Response Biomedical Corporation (TSX: RBM, OTCBB: RPBIF) today announced that its common shares have been approved for listing on the Toronto Stock Exchange...
More...
  Response Biomedical Corporation Announces Third Quarter Results
29 November 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) today reported financial results for the third quarter ended September 30, 2007...
More...
  Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange
6 November 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) is pleased to announce that the Toronto Stock Exchange (TSX) has conditionally approved...
More...
  Response Biomedical Appoints S. Wayne Kay Chief Executive Officer
12 September 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) today announced the appointment of S. Wayne Kay as Chief Executive Officer (CEO)...
More...
  Response Biomedical Corporation Announces Second Quarter Results
29 August 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) today reported financial results for the second quarter ended June 30, 2007...
More...
  Response Biomedical Closes $12 Million Bought Deal Private Placement
23 July 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) today announced that the Company has closed the financing announced July 9, 2007, raising gross...
More...
  Response Biomedical Announces $12 Million Bought Deal Private Placement
9 July 2007
Response Biomedical Corporation (TSX-V: RBM, OTCBB: RPBIF) today announced that the Company has entered into an agreement with Haywood Securities...
More...